APOPROTEIN A5 (APOA5) REDUCES ATHEROSCLEROSIS IN MICE

被引：2
|
作者：
Naumann, A. [1 ]
Heeren, J. [2 ]
Bruns, O. T. [2 ]
Thiery, J. [3 ]
Teupser, D.
Merkel, M. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med 3, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, IBM Mol Cell Biol 2, Hamburg, Germany
[3] Univ Hosp Leipzig, Inst Lab Med, Leipzig, Germany
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70145-4
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [41] APOA5 -: a recent addition to genes determining plasma triglycerides
    Talmud, PJ
    METABOLIC SYNDROME: DIABETES, OBESITY, HYPERLIPIDEMIA AND HYPERTENSION, 2003, 1253 : 79 - 84
  • [42] Mutations in APOA5 or LDLR increase risk of myocardial infarction
    Gregory B. Lim
    Nature Reviews Cardiology, 2015, 12 (2) : 64 - 64
  • [43] The APOA5 gene is associated with familial combined hyperlipidemia and dyslipidemia
    van der Vleuten, Gerly M.
    Isaacs, Aaron
    Zeng, Wu-Wei
    ter Avest, Ewoud
    Talmud, Philippa J.
    Dallinga-Thie, Geesje M.
    van Duijn, Cornelia M.
    Stalenhoef, Anton F.
    de Graaf, Jacqueline
    CIRCULATION, 2006, 114 (18) : 677 - 677
  • [44] APOA1/C3/A4/A5基因簇的新载脂蛋白基因:APOA5及其研究进展
    刘合焜
    张思仲
    苏智广
    马用信
    王春婷
    遗传, 2004, (06) : 953 - 956
  • [45] The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA5*2, and their paradoxical association with plasma triglyceride but not plasma apoAV levels
    Palmen, Jutta
    Smith, Andrew J. P.
    Dorfmeister, Birgit
    Putt, Wendy
    Humphries, Steve E.
    Talmud, Philippa J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2008, 1782 (7-8): : 447 - 452
  • [46] SATURATED FAT FROM DIET DOWNREGULATES APOA5 HEPATIC EXPRESSION IN APO E DEFICIENT MICE
    Guardiola, Montse
    Tous, Monica
    Carles Vallve, Joan
    Rull, Anna
    Masana, Lluis
    Joven, Jorge
    Ribalta, Josep
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2007, 19 (01): : 22 - 29
  • [47] Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states
    Perez-Martinez, Pablo
    Corella, Dolores
    Shen, Jian
    Arnett, Donna K.
    Yiannakouris, Nikos
    Tai, E. Syong
    Orho-Melander, Marju
    Tucker, Katherine L.
    Tsai, Michael
    Straka, Robert J.
    Province, Michael
    Kai, Chew Suok
    Perez-Jimenez, Francisco
    Lai, Chao-Qiang
    Lopez-Miranda, Jose
    Guillen, Marisa
    Parnell, Laurence D.
    Borecki, Ingrid
    Kathiresan, Sekar
    Ordovas, Jose M.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2009, 89 (01) : 391 - 399
  • [48] Mutation Screening of the APOA5 Gene in Subjects With Coronary Artery Disease
    Soufi, Muhidien
    Sattler, Alexander M.
    Kurt, Bilgen
    Schaefer, Juergen R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (07) : 1015 - 1019
  • [49] FIRST REPORTED APOA5 VARIANT IN LEBANON CAUSING HYPERCHYLOMICRONEMIA SYNDROME
    Ghaleb, Youmna
    Ayoub, Carine
    Halaby, Georges
    Azar, Yara
    Abou-Khalil, Yara
    Elbitar, Sandy
    El Khoury, Petra
    Abifadel, Marianne
    ATHEROSCLEROSIS, 2024, 399 : 57 - 58
  • [50] A Clinical Case of a Homozygous Deletion in the APOA5 Gene with Severe Hypertriglyceridemia
    Vasiluev, Petr Andreevich
    Ivanova, Olga N.
    Semenova, Natalia A.
    Strokova, Tatiana, V
    Taran, Natalia N.
    Chubykina, Uliana, V
    Ezhov, Marat, V
    Zakharova, Ekaterina Y.
    Dadli, Elena L.
    Kutsev, Sergey, I
    GENES, 2022, 13 (06)
12345